 | • レポートコード：QYR2104Z0706 • 出版社/出版日：QYResearch / 2021年4月10日 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、基底細胞がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、光線力学療法、薬剤）、用途別市場規模（小売薬局、病院薬局、がん研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・基底細胞がん治療の市場動向 ・企業の競争状況、市場シェア ・基底細胞がん治療の種類別市場規模（手術、放射線療法、光線力学療法、薬剤） ・基底細胞がん治療の用途別市場規模（小売薬局、病院薬局、がん研究機関） ・基底細胞がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・基底細胞がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・基底細胞がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・基底細胞がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・基底細胞がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sun Pharmaceuticals、Bausch Health、Mylan、F. Hoffmann-La Roche、Merck） ・結論 |
Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.
The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market.
Market Analysis and Insights: Global Basal Cell Carcinoma Therapeutics Market
The global Basal Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Basal Cell Carcinoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Basal Cell Carcinoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Basal Cell Carcinoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Basal Cell Carcinoma Therapeutics market.
Global Basal Cell Carcinoma Therapeutics Scope and Market Size
Basal Cell Carcinoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Basal Cell Carcinoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgery
Radiation Therapy
Photodynamic Therapy
Drugs
Segment by Application
Retail Pharmacies
Hospitals Pharmacies
Cancer Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sun Pharmaceuticals
Bausch Health
Mylan
F. Hoffmann-La Roche
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiation Therapy
1.2.4 Photodynamic Therapy
1.2.5 Drugs
1.3 Market by Application
1.3.1 Global Basal Cell Carcinoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospitals Pharmacies
1.3.4 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Basal Cell Carcinoma Therapeutics Market Perspective (2016-2027)
2.2 Basal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Basal Cell Carcinoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Basal Cell Carcinoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Basal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Basal Cell Carcinoma Therapeutics Industry Dynamic
2.3.1 Basal Cell Carcinoma Therapeutics Market Trends
2.3.2 Basal Cell Carcinoma Therapeutics Market Drivers
2.3.3 Basal Cell Carcinoma Therapeutics Market Challenges
2.3.4 Basal Cell Carcinoma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Basal Cell Carcinoma Therapeutics Players by Revenue
3.1.1 Global Top Basal Cell Carcinoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Basal Cell Carcinoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Basal Cell Carcinoma Therapeutics Revenue
3.4 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio
3.4.1 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Basal Cell Carcinoma Therapeutics Revenue in 2020
3.5 Basal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Basal Cell Carcinoma Therapeutics Product Solution and Service
3.7 Date of Enter into Basal Cell Carcinoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Basal Cell Carcinoma Therapeutics Breakdown Data by Type
4.1 Global Basal Cell Carcinoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2022-2027)
5 Basal Cell Carcinoma Therapeutics Breakdown Data by Application
5.1 Global Basal Cell Carcinoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
6.2 North America Basal Cell Carcinoma Therapeutics Market Size by Type
6.2.1 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Basal Cell Carcinoma Therapeutics Market Size by Application
6.3.1 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Basal Cell Carcinoma Therapeutics Market Size by Country
6.4.1 North America Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
7.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Type
7.2.1 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Application
7.3.1 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Basal Cell Carcinoma Therapeutics Market Size by Country
7.4.1 Europe Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
9.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type
9.2.1 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application
9.3.1 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Basal Cell Carcinoma Therapeutics Market Size by Country
9.4.1 Latin America Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sun Pharmaceuticals
11.1.1 Sun Pharmaceuticals Company Details
11.1.2 Sun Pharmaceuticals Business Overview
11.1.3 Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Introduction
11.1.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.1.5 Sun Pharmaceuticals Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Basal Cell Carcinoma Therapeutics Introduction
11.2.4 Bausch Health Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.2.5 Bausch Health Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Basal Cell Carcinoma Therapeutics Introduction
11.3.4 Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Basal Cell Carcinoma Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Basal Cell Carcinoma Therapeutics Introduction
11.5.4 Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Photodynamic Therapy
Table 5. Key Players of Drugs
Table 6. Global Basal Cell Carcinoma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Basal Cell Carcinoma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Basal Cell Carcinoma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Basal Cell Carcinoma Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Basal Cell Carcinoma Therapeutics Market Share by Regions (2022-2027)
Table 12. Basal Cell Carcinoma Therapeutics Market Trends
Table 13. Basal Cell Carcinoma Therapeutics Market Drivers
Table 14. Basal Cell Carcinoma Therapeutics Market Challenges
Table 15. Basal Cell Carcinoma Therapeutics Market Restraints
Table 16. Global Basal Cell Carcinoma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Basal Cell Carcinoma Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Basal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Therapeutics as of 2020)
Table 19. Ranking of Global Top Basal Cell Carcinoma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Basal Cell Carcinoma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Basal Cell Carcinoma Therapeutics Product Solution and Service
Table 23. Date of Enter into Basal Cell Carcinoma Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Basal Cell Carcinoma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sun Pharmaceuticals Company Details
Table 64. Sun Pharmaceuticals Business Overview
Table 65. Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Product
Table 66. Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Sun Pharmaceuticals Recent Development
Table 68. Bausch Health Company Details
Table 69. Bausch Health Business Overview
Table 70. Bausch Health Basal Cell Carcinoma Therapeutics Product
Table 71. Bausch Health Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Bausch Health Recent Development
Table 73. Mylan Company Details
Table 74. Mylan Business Overview
Table 75. Mylan Basal Cell Carcinoma Therapeutics Product
Table 76. Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Mylan Recent Development
Table 78. F. Hoffmann-La Roche Company Details
Table 79. F. Hoffmann-La Roche Business Overview
Table 80. F. Hoffmann-La Roche Basal Cell Carcinoma Therapeutics Product
Table 81. F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 82. F. Hoffmann-La Roche Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Basal Cell Carcinoma Therapeutics Product
Table 86. Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Basal Cell Carcinoma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiation Therapy Features
Figure 4. Photodynamic Therapy Features
Figure 5. Drugs Features
Figure 6. Global Basal Cell Carcinoma Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Retail Pharmacies Case Studies
Figure 8. Hospitals Pharmacies Case Studies
Figure 9. Cancer Research Institutes Case Studies
Figure 10. Basal Cell Carcinoma Therapeutics Report Years Considered
Figure 11. Global Basal Cell Carcinoma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Basal Cell Carcinoma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Basal Cell Carcinoma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Basal Cell Carcinoma Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Basal Cell Carcinoma Therapeutics Market Share by Players in 2020
Figure 16. Global Top Basal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Basal Cell Carcinoma Therapeutics Revenue in 2020
Figure 18. Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Basal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Basal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Basal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Basal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Basal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Basal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Basal Cell Carcinoma Therapeutics Market Share by Region (2016-2027)
Figure 40. China Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Basal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Basal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Basal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Basal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sun Pharmaceuticals Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 60. Bausch Health Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 61. Mylan Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed